Doppel Farmaceutici, an Italian portfolio company of Trilantic Europe, has acquired Dietopack

Trilantic Europe’s portfolio company, Doppel Farmaceutici,  has acquired 90% of Dietopack, a leading Italian contract development and manufacturing organization (CDMO).

Doppel’s acquisition of Dietopack creates a larger, more diversified and fully integrated CDMO operator offering pharmaceutical, nutraceutical and pet products to its client base, further consolidating the company’s market leading position as the second largest CDMO in Italy.

Vittorio Pignatti, Chairman of Trilantic Europe commented, “The recent add-on acquisitions executed by our healthcare portfolio companies show that our continued focus on growth through active buy-and-build strategies is working even in today’s challenging environment.”

Lincoln International acted as the exclusive debt advisor to Doppel and supported all aspects of the financing process including lender approach and structuring and negotiating of the financing. Lincoln International was able to support Doppel in determining the optimal financing structure and securing a competitive bank financing.

About Dietopack

Headquartered in Emilia Romagna and with 60 employees, Dietopack focuses on nutraceutical products (representing 80% of revenues) and pet nutritionals, producing probiotics, vitamins, minerals, nutritional supplements and high protein dietary supplements mainly distributed through pharmacies by its clients.

About Trilantic Europe

Trilantic Europe is a leading private equity firm focusing on mid-market transactions, tailoring solutions for businesses using its expertise and operating knowledge to accelerate growth and enhance value creation. Trilantic Europe’s sectors of focus are healthcare, consumer and leisure, industrials, TMT and business services.

About Doppel Farmaceutici

Founded in 1994, Doppel Farmaceutici is a leading pharma contract development and contract manufacturing company, which employs over 550 people.

Share: